OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Gastroenterology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention	316
Temporal trends in obesity and its prognostic impact in Korean patients with inflammatory bowel disease	247
WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway	176
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom	138
A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials	95
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando	85
Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis	73
LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice	64
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study	56
A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy	53
Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel	46
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis	45
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv	43
Impact of preceding treatment for head and neck squamous cell carcinoma on synchronous superficial esophageal squamous cell carcinoma	42
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	38
The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis	37
Utility of a new automated diagnostic program in high-resolution esophageal manometry	37
HBeAg-positive patients with HBsAg < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation	37
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis	36
Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B	35
Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study	32
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation	30
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells	30
The useful predictors of zinc deficiency for the management of chronic liver disease	29
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia	26

Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	26
Renal manifestations in inflammatory bowel disease: a systematic review	26